Patent: 6,872,739
✉ Email this page to a colleague
Summary for Patent: 6,872,739
Title: | Use of riluzole for the treatment of multiple sclerosis |
Abstract: | Methods for the treatment of multiple sclerosis are disclosed comprising administering 6-(triflouromethoxy)-2-benzothiazolamine or a salt thereof. |
Inventor(s): | Polman; Chris (Overveen, NL) |
Assignee: | Vereniging Voor Christelijk Wetenshappelikjk Onderwijs (Amsterdam, NL) |
Application Number: | 09/926,693 |
Patent Claims: | see list of patent claims |
Details for Patent 6,872,739
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Bayer Healthcare Pharmaceuticals Inc. | BETASERON | interferon beta-1b | For Injection | 103471 | 07/23/1993 | ⤷ Try a Trial | 2019-06-04 |
Biogen Inc. | AVONEX | interferon beta-1a | For Injection | 103628 | 05/17/1996 | ⤷ Try a Trial | 2019-06-04 |
Biogen Inc. | AVONEX | interferon beta-1a | Injection | 103628 | 05/28/2003 | ⤷ Try a Trial | 2019-06-04 |
Biogen Inc. | AVONEX | interferon beta-1a | Injection | 103628 | 02/27/2012 | ⤷ Try a Trial | 2019-06-04 |
Emd Serono, Inc. | REBIF | interferon beta-1a | Injection | 103780 | 03/07/2002 | ⤷ Try a Trial | 2019-06-04 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |